ZA977402B - A DNA and a method of preparing a protein thereby - Google Patents

A DNA and a method of preparing a protein thereby

Info

Publication number
ZA977402B
ZA977402B ZA977402A ZA977402A ZA977402B ZA 977402 B ZA977402 B ZA 977402B ZA 977402 A ZA977402 A ZA 977402A ZA 977402 A ZA977402 A ZA 977402A ZA 977402 B ZA977402 B ZA 977402B
Authority
ZA
South Africa
Prior art keywords
dna
protein
preparing
Prior art date
Application number
ZA977402A
Other languages
English (en)
Inventor
Nobuaki Nakagawa
Hisataka Yasuda
Tomonori Morinaga
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of ZA977402B publication Critical patent/ZA977402B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA977402A 1996-08-19 1997-08-18 A DNA and a method of preparing a protein thereby ZA977402B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規ｄｎａ及びそれを用いた蛋白質の製造方法

Publications (1)

Publication Number Publication Date
ZA977402B true ZA977402B (en) 1999-02-18

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA977402A ZA977402B (en) 1996-08-19 1997-08-18 A DNA and a method of preparing a protein thereby

Country Status (12)

Country Link
EP (1) EP0874045A1 (enExample)
JP (1) JPH1057071A (enExample)
KR (1) KR20000064276A (enExample)
CN (1) CN1198776A (enExample)
AU (1) AU718458B2 (enExample)
CA (1) CA2235148A1 (enExample)
FI (1) FI980853A7 (enExample)
HU (1) HUP0001837A3 (enExample)
NO (1) NO981748L (enExample)
NZ (1) NZ330400A (enExample)
WO (1) WO1998007840A1 (enExample)
ZA (1) ZA977402B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
DE69740107D1 (de) 1996-12-23 2011-03-10 Immunex Corp Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie
ES2263204T5 (es) 1997-04-15 2013-10-14 Daiichi Sankyo Company, Limited Nueva proteína y proceso para producir la misma
ES2284203T5 (es) 1997-04-16 2016-03-11 Amgen Inc. Proteínas de unión a osteoprotegerina y sus receptores
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
JP4268684B2 (ja) 1997-09-24 2009-05-27 第一三共株式会社 骨代謝異常症の診断方法
AU762574B2 (en) 1998-05-14 2003-06-26 Immunex Corporation Method of inhibiting osteoclast activity
HUP0104126A3 (en) 1998-10-28 2004-07-28 Sankyo Company Ltd Chuo Ku Remedies for bone metabolic errors
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
AU7720600A (en) * 1999-09-27 2001-04-30 Eli Lilly And Company Osteoprotegerin regulatory region
EP1377610A2 (en) 2001-04-03 2004-01-07 Société des Produits Nestlé S.A. Osteoprotegerin in milk
US7064189B2 (en) 2001-05-25 2006-06-20 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to trail receptors
US7718776B2 (en) 2002-04-05 2010-05-18 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
NZ330400A (en) 1999-05-28
CA2235148A1 (en) 1998-02-26
NO981748D0 (no) 1998-04-17
FI980853A0 (fi) 1998-04-17
FI980853L (fi) 1998-06-15
MX9803086A (es) 1998-11-29
KR20000064276A (ko) 2000-11-06
HUP0001837A2 (hu) 2000-09-28
CN1198776A (zh) 1998-11-11
EP0874045A1 (en) 1998-10-28
WO1998007840A1 (fr) 1998-02-26
AU3866197A (en) 1998-05-11
FI980853A7 (fi) 1998-06-15
JPH1057071A (ja) 1998-03-03
HUP0001837A3 (en) 2002-09-30
NO981748L (no) 1998-06-18
EP0874045A4 (enExample) 1998-11-18
AU718458B2 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
PL331285A1 (en) Erythromycins and method of preparing them
GB9626815D0 (en) Method of sequencing DNA
GB9620209D0 (en) Method of sequencing DNA
EP0725145A4 (en) PROTEIN MODIFICATION PROCESS
EP1027450A4 (en) METHOD FOR DNA SHUFFLING
PL339268A1 (en) Rapid marking-out method and system
PL318128A1 (en) Polymer-polyol and method of obtaining polymer-polyols
IL131486A0 (en) Gene sequencer and methods
GB2311192B (en) Data-transmitter-receiver and method of operation
ZA977402B (en) A DNA and a method of preparing a protein thereby
HUP0003206A3 (en) Methods of preparing and purifying 9-nitro-20-camptothecin
IL118375A0 (en) Rhesus OB protein and DNA
AU6565896A (en) DNA sequencing method and DNA sample preparation method
EP0699475A4 (en) DEFROSTING MATERIAL AND DEFROSTING METHOD
AU5369396A (en) Rest protein and dna
AU5224998A (en) Hair-curler and method for setting hair
GB9724270D0 (en) Methods and means for mutagenesis of dna
AU4289896A (en) Artificial nail and method for making same
GB9512092D0 (en) Proteins and nucleic acids
GB9310227D0 (en) Protein and dna
GB9706078D0 (en) Screening method and proteins and dna identified thereby
GB9502480D0 (en) DNA and protein sequences
GB9603149D0 (en) Protein kinase and method of using
ZA983159B (en) Protein and method for producing the proteins
IL129241A0 (en) Nucleotide and protein sequence of mammastatin and methods of use